BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 21379335)

  • 21. An EBNA3A-Mutated Epstein-Barr Virus Retains the Capacity for Lymphomagenesis in a Cord Blood-Humanized Mouse Model.
    Romero-Masters JC; Ohashi M; Djavadian R; Eichelberg MR; Hayes M; Zumwalde NA; Bristol JA; Nelson SE; Ma S; Ranheim EA; Gumperz JE; Johannsen EC; Kenney SC
    J Virol; 2020 May; 94(10):. PubMed ID: 32132242
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An Epstein-Barr virus anti-apoptotic protein constitutively expressed in transformed cells and implicated in burkitt lymphomagenesis: the Wp/BHRF1 link.
    Kelly GL; Long HM; Stylianou J; Thomas WA; Leese A; Bell AI; Bornkamm GW; Mautner J; Rickinson AB; Rowe M
    PLoS Pathog; 2009 Mar; 5(3):e1000341. PubMed ID: 19283066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel persistence associated EBV miRNA expression profile is disrupted in neoplasia.
    Qiu J; Cosmopoulos K; Pegtel M; Hopmans E; Murray P; Middeldorp J; Shapiro M; Thorley-Lawson DA
    PLoS Pathog; 2011 Aug; 7(8):e1002193. PubMed ID: 21901094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. EBV-miR-BHRF1-2 targets PRDM1/Blimp1: potential role in EBV lymphomagenesis.
    Ma J; Nie K; Redmond D; Liu Y; Elemento O; Knowles DM; Tam W
    Leukemia; 2016 Mar; 30(3):594-604. PubMed ID: 26530011
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epstein-Barr virus BamHI W repeat number limits EBNA2/EBNA-LP coexpression in newly infected B cells and the efficiency of B-cell transformation: a rationale for the multiple W repeats in wild-type virus strains.
    Tierney RJ; Kao KY; Nagra JK; Rickinson AB
    J Virol; 2011 Dec; 85(23):12362-75. PubMed ID: 21957300
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spontaneous lymphoblastoid cell lines from patients with Epstein-Barr virus infection show highly variable proliferation characteristics that correlate with the expression levels of viral microRNAs.
    Delecluse S; Yu J; Bernhardt K; Haar J; Poirey R; Tsai MH; Kiblawi R; Kopp-Schneider A; Schnitzler P; Zeier M; Dreger P; Wuchter P; Bulut OC; Behrends U; Delecluse HJ
    PLoS One; 2019; 14(9):e0222847. PubMed ID: 31568538
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Next-generation sequencing of miRNAs in clinical samples of Epstein-Barr virus-associated B-cell lymphomas.
    Sakamoto K; Sekizuka T; Uehara T; Hishima T; Mine S; Fukumoto H; Sato Y; Hasegawa H; Kuroda M; Katano H
    Cancer Med; 2017 Mar; 6(3):605-618. PubMed ID: 28181423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conserved sequences of BART and BHRF regions encoding viral microRNAs in Epstein-Barr virus-associated lymphoma.
    Sunagawa K; Hishima T; Fukumoto H; Hasegawa H; Katano H
    BMC Res Notes; 2017 Jul; 10(1):279. PubMed ID: 28705173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epstein-Barr virus microRNAs are evolutionarily conserved and differentially expressed.
    Cai X; Schäfer A; Lu S; Bilello JP; Desrosiers RC; Edwards R; Raab-Traub N; Cullen BR
    PLoS Pathog; 2006 Mar; 2(3):e23. PubMed ID: 16557291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The viral and cellular microRNA targetome in lymphoblastoid cell lines.
    Skalsky RL; Corcoran DL; Gottwein E; Frank CL; Kang D; Hafner M; Nusbaum JD; Feederle R; Delecluse HJ; Luftig MA; Tuschl T; Ohler U; Cullen BR
    PLoS Pathog; 2012 Jan; 8(1):e1002484. PubMed ID: 22291592
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The latency pattern of Epstein-Barr virus infection and viral IL-10 expression in cutaneous natural killer/T-cell lymphomas.
    Xu ZG; Iwatsuki K; Oyama N; Ohtsuka M; Satoh M; Kikuchi S; Akiba H; Kaneko F
    Br J Cancer; 2001 Apr; 84(7):920-5. PubMed ID: 11286472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. EBNA2-deleted Epstein-Barr virus (EBV) isolate, P3HR1, causes Hodgkin-like lymphomas and diffuse large B cell lymphomas with type II and Wp-restricted latency types in humanized mice.
    Li C; Romero-Masters JC; Huebner S; Ohashi M; Hayes M; Bristol JA; Nelson SE; Eichelberg MR; Van Sciver N; Ranheim EA; Scott RS; Johannsen EC; Kenney SC
    PLoS Pathog; 2020 Jun; 16(6):e1008590. PubMed ID: 32542010
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epstein-Barr Virus miR-BHRF1-3 Targets the BZLF1 3'UTR and Regulates the Lytic Cycle.
    Fachko DN; Chen Y; Skalsky RL
    J Virol; 2022 Feb; 96(4):e0149521. PubMed ID: 34878852
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The microRNAs of Epstein-Barr Virus are expressed at dramatically differing levels among cell lines.
    Pratt ZL; Kuzembayeva M; Sengupta S; Sugden B
    Virology; 2009 Apr; 386(2):387-97. PubMed ID: 19217135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Epstein-Barr virus (EBV)-induced tumor suppressor microRNA MiR-34a is growth promoting in EBV-infected B cells.
    Forte E; Salinas RE; Chang C; Zhou T; Linnstaedt SD; Gottwein E; Jacobs C; Jima D; Li QJ; Dave SS; Luftig MA
    J Virol; 2012 Jun; 86(12):6889-98. PubMed ID: 22496226
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of promoter methylation in Epstein-Barr virus (EBV) microRNA expression in EBV-infected B cell lines.
    Kim DN; Song YJ; Lee SK
    Exp Mol Med; 2011 Jul; 43(7):401-10. PubMed ID: 21628990
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Down-regulation of BLIMP1α by the EBV oncogene, LMP-1, disrupts the plasma cell differentiation program and prevents viral replication in B cells: implications for the pathogenesis of EBV-associated B-cell lymphomas.
    Vrzalikova K; Vockerodt M; Leonard S; Bell A; Wei W; Schrader A; Wright KL; Kube D; Rowe M; Woodman CB; Murray PG
    Blood; 2011 Jun; 117(22):5907-17. PubMed ID: 21411757
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of microRNAs in Epstein-Barr virus latency and lytic reactivation.
    Forte E; Luftig MA
    Microbes Infect; 2011 Dec; 13(14-15):1156-67. PubMed ID: 21835261
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evolutionary conservation of primate lymphocryptovirus microRNA targets.
    Skalsky RL; Kang D; Linnstaedt SD; Cullen BR
    J Virol; 2014 Feb; 88(3):1617-35. PubMed ID: 24257599
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lactic Acid Downregulates Viral MicroRNA To Promote Epstein-Barr Virus-Immortalized B Lymphoblastic Cell Adhesion and Growth.
    Mo X; Wei F; Tong Y; Ding L; Zhu Q; Du S; Tan F; Zhu C; Wang Y; Yu Q; Liu Y; Robertson ES; Yuan Z; Cai Q
    J Virol; 2018 May; 92(9):. PubMed ID: 29444941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.